NCT02041273 - Relative Bioavailability Of Palbociclib (PD-0332991) Under Fed And Fasted Conditions | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions

Healthy

Interventions

DRUG

palbociclib isethionate (phase 1 and 2 studies)

125 mg palbociclib isethionate salt under overnight fasting conditions

DRUG

palbociclib isethionate (phase 1 and 2 studies)

125 mg palbociclib isethionate salt under minimal fasting conditions (1 hr before palbociclib administration and 2 hrs post dose)

DRUG

palbociclib commercial free base capsule

125 mg palbociclib commercial free base capsule under fed conditions ( moderate fat meal)

Trial Locations (1)

Pfizer Investigational Site, New Haven